NCT04586712View on ClinicalTrials.gov

Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

March 21, 2024

Study Completion Date

March 21, 2024

Conditions
Muscle InjuryRecoveryPain Relief
Interventions
DRUG

Active CBD

Participants will be provided a viscous liquid in a bottle with a syringe dropper containing CBD-extract oil at concentrations of 2000mg/30mL (high).

DRUG

Vehicle Control (Placebo)

Participants will be provided a viscous liquid in a bottle with a syringe dropper containing placebo containing no CBD oil (0mg/30 mL).

Trial Locations (1)

32611

University of Florida, Gainesville

All Listed Sponsors
collaborator

Consortium for Medical Marijuana Clinical Outcomes Research

OTHER

lead

University of Florida

OTHER

NCT04586712 - Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury | Biotech Hunter | Biotech Hunter